Cargando…

The Compelling Case for Anti-CD3 in Type 1 Diabetes

Detalles Bibliográficos
Autor principal: Skyler, Jay S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3806623/
https://www.ncbi.nlm.nih.gov/pubmed/24158991
http://dx.doi.org/10.2337/db13-1157
_version_ 1782288403546505216
author Skyler, Jay S.
author_facet Skyler, Jay S.
author_sort Skyler, Jay S.
collection PubMed
description
format Online
Article
Text
id pubmed-3806623
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-38066232014-11-01 The Compelling Case for Anti-CD3 in Type 1 Diabetes Skyler, Jay S. Diabetes Commentary American Diabetes Association 2013-11 2013-10-18 /pmc/articles/PMC3806623/ /pubmed/24158991 http://dx.doi.org/10.2337/db13-1157 Text en © 2013 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.
spellingShingle Commentary
Skyler, Jay S.
The Compelling Case for Anti-CD3 in Type 1 Diabetes
title The Compelling Case for Anti-CD3 in Type 1 Diabetes
title_full The Compelling Case for Anti-CD3 in Type 1 Diabetes
title_fullStr The Compelling Case for Anti-CD3 in Type 1 Diabetes
title_full_unstemmed The Compelling Case for Anti-CD3 in Type 1 Diabetes
title_short The Compelling Case for Anti-CD3 in Type 1 Diabetes
title_sort compelling case for anti-cd3 in type 1 diabetes
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3806623/
https://www.ncbi.nlm.nih.gov/pubmed/24158991
http://dx.doi.org/10.2337/db13-1157
work_keys_str_mv AT skylerjays thecompellingcaseforanticd3intype1diabetes
AT skylerjays compellingcaseforanticd3intype1diabetes